These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38880525)
1. Animal models of neglected parasitic diseases: In vivo multimodal imaging of experimental trypanosomatid infections. Tsagmo JMN; Rotureau B; Calvo Alvarez E Methods Cell Biol; 2024; 188():205-236. PubMed ID: 38880525 [TBL] [Abstract][Full Text] [Related]
2. A new chimeric triple reporter fusion protein as a tool for in vitro and in vivo multimodal imaging to monitor the development of African trypanosomes and Leishmania parasites. Calvo-Alvarez E; Cren-Travaillé C; Crouzols A; Rotureau B Infect Genet Evol; 2018 Sep; 63():391-403. PubMed ID: 29339220 [TBL] [Abstract][Full Text] [Related]
3. A panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection models. Van Reet N; Van de Vyver H; Pyana PP; Van der Linden AM; Büscher P PLoS Negl Trop Dis; 2014 Aug; 8(8):e3054. PubMed ID: 25144573 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Bioluminescence Imaging to Assess Compound Efficacy Against Trypanosoma brucei. Ritchie R; Barrett MP; Mottram JC; Myburgh E Methods Mol Biol; 2020; 2116():801-817. PubMed ID: 32221957 [TBL] [Abstract][Full Text] [Related]
5. Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase. McLatchie AP; Burrell-Saward H; Myburgh E; Lewis MD; Ward TH; Mottram JC; Croft SL; Kelly JM; Taylor MC PLoS Negl Trop Dis; 2013 Nov; 7(11):e2571. PubMed ID: 24278497 [TBL] [Abstract][Full Text] [Related]
6. A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasis. Burrell-Saward H; Rodgers J; Bradley B; Croft SL; Ward TH J Antimicrob Chemother; 2015 Feb; 70(2):510-7. PubMed ID: 25298516 [TBL] [Abstract][Full Text] [Related]
7. Imaging Infection by Vector-Borne Protozoan Parasites Using Whole-Mouse Bioluminescence. Sá M; Costa DM; Tavares J Methods Mol Biol; 2022; 2524():353-367. PubMed ID: 35821487 [TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of pathogen homing to the host tissues. Tavares J; Costa DM; Teixeira AR; Cordeiro-da-Silva A; Amino R Methods; 2017 Aug; 127():37-44. PubMed ID: 28522323 [TBL] [Abstract][Full Text] [Related]
10. Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness. Claes F; Vodnala SK; van Reet N; Boucher N; Lunden-Miguel H; Baltz T; Goddeeris BM; Büscher P; Rottenberg ME PLoS Negl Trop Dis; 2009 Jul; 3(7):e486. PubMed ID: 19621071 [TBL] [Abstract][Full Text] [Related]
11. Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions. Taylor MC; Francisco AF; Jayawardhana S; Mann GS; Ward AI; Olmo F; Lewis MD; Kelly JM Methods Mol Biol; 2019; 1955():147-163. PubMed ID: 30868525 [TBL] [Abstract][Full Text] [Related]
12. New fluorescence markers to distinguish co-infecting Trypanosoma brucei strains in experimental multiple infections. Balmer O; Tostado C Acta Trop; 2006 Jan; 97(1):94-101. PubMed ID: 16212925 [TBL] [Abstract][Full Text] [Related]
16. 2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach. Mercer L; Bowling T; Perales J; Freeman J; Nguyen T; Bacchi C; Yarlett N; Don R; Jacobs R; Nare B PLoS Negl Trop Dis; 2011 Feb; 5(2):e956. PubMed ID: 21347454 [TBL] [Abstract][Full Text] [Related]
17. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp. Scarim CB; Chelucci RC; Dos Santos JL; Chin CM Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962 [TBL] [Abstract][Full Text] [Related]
18. VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains. So J; Sudlow S; Sayeed A; Grudda T; Deborggraeve S; Ngoyi DM; Desamber DK; Wickstead B; Lejon V; Mugnier MR mBio; 2022 Dec; 13(6):e0255322. PubMed ID: 36354333 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma brucei Tim50 Possesses PAP Activity and Plays a Critical Role in Cell Cycle Regulation and Parasite Infectivity. Tripathi A; Singha UK; Cooley A; Gillyard T; Krystofiak E; Pratap S; Davis J; Chaudhuri M mBio; 2021 Oct; 12(5):e0159221. PubMed ID: 34517757 [TBL] [Abstract][Full Text] [Related]
20. Depletion of the extracellular-signal regulated kinase 8 homolog in Trypanosoma brucei in vivo reduces its virulence in a mouse target validation study. Elaadli H; Kim I; Mackey ZB Mol Biochem Parasitol; 2018 Mar; 220():1-4. PubMed ID: 29287675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]